Status:

UNKNOWN

Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults

Lead Sponsor:

Far Eastern Memorial Hospital

Conditions:

Hepatitis B

Eligibility:

All Genders

18-20 years

Brief Summary

The aim of this study is to observe and evaluate initiate serum anti-HBs titers during entrance health examination among undergraduate freshmen in a university who showed a complete 4-dose HBV vaccina...

Detailed Description

Hepatitis-B virus infection is endemic in Taiwan with 90% of the adult population having been previously infected with HBV at some stage in their lives, and with approximately 15 - 20% of the general ...

Eligibility Criteria

Inclusion

  • 18-20 years old college new entrants who had complete 4-dose HB vaccination in their infancy

Exclusion

  • 18-20 years old college new entrants who did not complete a 4-dose HB vaccination in their infancy

Key Trial Info

Start Date :

October 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2008

Estimated Enrollment :

1800 Patients enrolled

Trial Details

Trial ID

NCT00702663

Start Date

October 1 2007

End Date

October 1 2008

Last Update

June 20 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yuan Ze University

Taipei, Taiwan

Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults | DecenTrialz